| Management target | Revenue FY27 |
|---|
| Revenue growth | 26.0% YoY growth in Q1FY27. |
|---|---|
| Margins | EBITDA margin improved 30 bps YoY to 28.5%. |
| Demand visibility | Strong; 882K+ patients served in Q1, up 25.1% YoY. |
| Management confidence | High, citing 'highest ever quarterly addition of surgical facilities'. |
Growth
Revenue grew 26.0% YoY to ₹614 Cr; PAT surged 44.6% YoY to ₹55 Cr. Surgeries performed increased by 15.5%.
Outlook
Planned addition of 42 more facilities in FY27 (12 in Q2, 30 in H2). Targeting 60 total new facilities for FY27.
Risks
Expansion maturity risks; emerging facilities currently contribute 21.0% of revenues and require scaling to optimize margins.
Last quarter's promises, checked
Delivered
- Guided 60 new facilities for FY27 → delivered 18 in Q1 (= BEAT)
- Targeted 30 surgical centers in FY26 → delivered 30 (= BEAT)
- Guided stable EBITDA margins → delivered 28.5% (+30 bps YoY) (= BEAT)
Partly delivered
- Guided 60 total new facilities for FY27 → 42 remaining to be added (= PARTIAL)
Investor Presentation filed with BSE, NSE: AGARWALEYE. Summary written with AI assistance from the document.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹485.85
- Market cap
- ₹15,403 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 103.8×Sector 53.1×
- Promoter holding
- 32.34%-0.02% QoQ
- FII holding
- 57.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Annual General Meeting
Dr. Agarwal's Health Care Limited held its 16th AGM on September 21, 2026. Shareholders approved all agenda items, including financial statements and director re-appointments.
Dr. Agarwals Health Care Annual General Meeting
Dr. Agarwal's Health Care Limited has issued the notice for its Sixteenth Annual General Meeting, scheduled for September 21, 2026, alongside its FY 2025-26 Annual Report.
Dr. Agarwals Health Care Capacity Expansion
Dr. Agarwals Eye Hospital, a subsidiary, launched the World's First Pinhole Pupilloplasty Centre in Chennai. This facility advances specialized surgical treatments for complex corneal disorders.
Dr. Agarwals Health Care Share Pledge
Catalyst Trusteeship Limited reported the creation of a pledge over 7,538,303 equity shares of Dr. Agarwal's Health Care Limited, representing 2.38% of its capital.
- Value
- ₹950.0 Cr
Dr. Agarwals Health Care Share Pledge
DB International Trust disclosed a partial release of pledge and disposal of 24,160,000 shares in Dr. Agarwal’s Health Care Ltd. The disclosure complies with Reg 29(2).
Dr. Agarwals Health Care Share Pledge
Catalyst Trusteeship Limited reported a release of pledge over 3,16,98,303 equity shares of Dr. Agarwal's Health Care Limited. The transaction pertains to a USD 100 million facility.
- Value
- ₹950.0 Cr